Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical Files Expanded Access Protocol With FDA for Toraymyxin(TM) Septic Shock Treatment

MarketWire Canada May 31, 2016

CORRECTION FROM SOURCE: Spectral Announces Fourth Quarter and Fiscal 2015 Results

Marketwired March 30, 2016

Spectral Announces Fourth Quarter and Fiscal 2015 Results

Marketwired March 30, 2016

Spectral Commends Inclusion of Organ Dysfunction in New Expert Consensus Definitions of Sepsis and Septic Shock

Marketwired March 7, 2016

Spectral Approaches Finish Line for Clinical and Regulatory Program

Marketwired March 1, 2016

Spectral Medical Inc. Closes Over-Allotment

Marketwired February 24, 2016

Spectral Medical Inc. Completes $10 Million Bought Deal Financing

Marketwired February 18, 2016

Spectral Medical Inc. Announces $10,010,000 Bought Deal Financing

Marketwired January 28, 2016

Spectral Medical Provides Clinical and Regulatory Update

Marketwired January 11, 2016

CORRECTION: Spectral Announces Third Quarter 2015 Results

Marketwired November 13, 2015

Spectral Announces Third Quarter 2015 Results

Marketwired November 13, 2015

Spectral Files Third Module of Rolling PMA Submission to FDA

Marketwired November 12, 2015

Spectral Announces European Distribution Agreement With Fresenius Medical Care for Its Endotoxin Activity Assay (EAA(TM)) Diagnostic

Marketwired November 10, 2015

Spectral Announces European Distribution Agreement With Fresenius Medical Care for Its Endotoxin Activity Assay (EAA(TM)) Diagnostic

Marketwired November 10, 2015

Spectral Announces Presentations By Key Opinion Leaders at the Critical Care Canada Forum

Marketwired October 26, 2015

Spectral and Toray Medical Sign Exclusive EAA(TM) Distribution Agreement for 15 Countries in the Middle and Far East

Marketwired October 21, 2015

Body of Evidence Supporting the Use of Toraymyxin(TM) for Treatment of Septic Shock Continues to Grow

Marketwired October 19, 2015

IIROC Trade Resumption - Spectral Medical Inc.

Newsfile September 14, 2015

Spectral Now Recruiting the Last 75 Patients in Its Phase III Trial

Marketwired September 14, 2015

IIROC Trade Halt - Spectral Medical Inc.

Newsfile September 14, 2015